Finance

Beta
Lists
BIOG-B:STO
BioGaia AB
SEK 130.30
+4.74%
(+5.90) 1D
May 29, 5:29:35 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOG-B...
Open
SEK 124.70
High
SEK 130.30
Low
SEK 124.60
Mkt. cap
12.25B
Avg. vol.
173.29K
Volume
498.32K
52-wk high
SEK 136.30
52-wk low
SEK 93.20
Shares outstanding
98.50M
No. of employees
242
Open
SEK 124.70
High
SEK 130.30
Low
SEK 124.60
Mkt. cap
12.25B
Avg. vol.
173.29K
Volume
498.32K
52-wk high
SEK 136.30
52-wk low
SEK 93.20
Shares outstanding
98.50M
No. of employees
242
News stories
From sources across the web
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
CEOTheresa Agnew
Employees242
Founded1990
Headquarters-
SectorBiotechnology
Websitebiogaiagroup.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
404.69M
326.64M
440.57M
372.55M
Cost of goods sold
110.81M
84.13M
116.74M
105.77M
Cost of revenue
110.81M
84.13M
116.74M
105.77M
Research and development expenses
30.39M
25.88M
36.79M
25.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
150.35M
126.67M
159.68M
145.89M
Operating expense
180.74M
152.54M
196.47M
165.63M
Total operating expenses
291.55M
236.68M
313.21M
271.40M
Operating income
113.14M
89.96M
127.36M
101.15M
Other non operating income
-1.00K
1.00K
-2.39M
-
EBT including unusual items
110.40M
85.32M
123.58M
101.50M
EBT excluding unusual items
110.40M
87.52M
117.88M
101.50M
Income tax expense
22.50M
19.44M
24.80M
22.10M
Effective tax rate
20.38%
22.78%
20.07%
21.77%
Other operating expenses
-
-
-
-5.79M
Net income
87.91M
65.88M
98.78M
79.41M
Net profit margin
21.72%
20.17%
22.42%
21.32%
Earnings per share
0.87
0.65
0.98
0.78
Interest and investment income
4.58M
2.93M
2.81M
2.34M
Interest expense
-2.52M
-1.39M
-3.49M
-1.99M
Net interest expenses
2.06M
1.54M
-677.00K
351.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
119.34M
96.10M
133.49M
107.29M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer